Czechia, June 17 -- Czechia based Gilead Sciences s.r.o. has secured contract from Fakultni nemocnice Olomouc for Antineoplastic agents - LP containing sacituzumab govitecan 2026 . The value of the contract is worth 412182000 CZK .
Published by HT Digital Content Services with permission from Pivotal Sources....